Network Meta-analysis of Seven Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Outcome Trials Data

被引：1
|
作者：
Alfayez, Osamah
Alkhezi, Omar
Almutairi, Abdulaali R.
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-445-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
445-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cardiovascular and microvascular outcomes of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled cardiovascular outcome trials with trial sequential analysis
    Zhang, Xiaowen
    Shao, Fei
    Zhu, Lin
    Ze, Yuyang
    Zhu, Dalong
    Bi, Yan
    BMC PHARMACOLOGY & TOXICOLOGY, 2018, 19
  • [32] Cardiovascular and microvascular outcomes of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled cardiovascular outcome trials with trial sequential analysis
    Xiaowen Zhang
    Fei Shao
    Lin Zhu
    Yuyang Ze
    Dalong Zhu
    Yan Bi
    BMC Pharmacology and Toxicology, 19
  • [33] Effect of the glucagon-like peptide-1 receptor agonists on diabetic peripheral neuropathy: A meta-analysis
    Fan, Shujin
    Qiu, Yue
    Liu, Jing
    Zhu, Tianxin
    Wang, Chuan
    Liu, Dan
    Yan, Li
    Ren, Meng
    JOURNAL OF NEUROCHEMISTRY, 2025, 169 (02)
  • [34] GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS DO NOT DECREASE THE RISK FOR CORONARY REVASCULARIZATION IN PATIENTS WITH TYPE 2 DIABETES: A META-ANALYSIS OF CARDIOVASCULAR OUTCOME TRIALS
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Siskos, Fotios
    Kassimis, George
    Petidis, Konstantinos
    Papadopoulos, Christodoulos
    Karagiannis, Asterios
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E164 - E164
  • [35] Potential Cardiovascular Effects of the Glucagon-like Peptide-1 Receptor Agonists
    Chilton, Robert J.
    JOURNAL OF DIABETES & METABOLISM, 2015, 6 (01)
  • [36] Weight-Lowering Efficacy of Glucagon-Like Peptide-1 Receptor Agonists: A Meta-Analysis
    Vilsboll, Tina
    Knop, Filip K.
    Christensen, Mikkel
    Gluud, Lise L.
    DIABETES, 2011, 60 : A315 - A315
  • [37] A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists
    Hu, En-Hao
    Tsai, Ming-Lung
    Lin, Yuan
    Chou, Tien-Shin
    Chen, Tien-Hsing
    MEDICINA-LITHUANIA, 2024, 60 (03):
  • [38] Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: a meta-analysis
    Li, Mingxia
    Lin, Hong
    Yang, Qianru
    Zhang, Xiaolong
    Zhou, Qiong
    Shi, Jiankuan
    Ge, Fangfang
    SLEEP, 2024,
  • [39] Number needed to treat in cardiovascular outcome trials of glucagon-like peptide-1 receptor agonists: A systematic review with temporal analysis
    Davies, Melanie J.
    Kloecker, David E.
    Webb, David R.
    Khunti, Kamlesh
    Zaccardi, Francesco
    DIABETES OBESITY & METABOLISM, 2020, 22 (09): : 1670 - 1677
  • [40] Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials
    Monami, Matteo
    Dicembrini, Ilaria
    Nreu, Besmir
    Andreozzi, Francesco
    Sesti, Giorgio
    Mannucci, Edoardo
    ACTA DIABETOLOGICA, 2017, 54 (12) : 1101 - 1114
12345